The XEC COVID-19 variant, first identified in Europe, now accounts for 45 percent of cases in the United States, according to the Centers for Disease Control and Prevention (CDC). As infections tick ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

Here, doctors who have seen it all and help you differentiate whether you've got a cold, COVID or another seasonal delight ...

Leading the charge now silently—because viruses don’t talk—is the XEC variant of the SARS-CoV-2. The Centers for Disease Control and Prevention estimated that the XEC variant has comprised ...

Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...

Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda ...

The landscape of Covid-19 continues to evolve in 2024, with the XEC variant emerging as the main concern during this winter season. This mutation of the Omicron strain now represents 45% of all ...

Although the worst of COVID-19 may be behind us, Springfield’s Health and Human Services Commissioner Helen Caulton-Harris ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

The most common, dominant COVID variant as 2024 comes to a close is XEC, according to the Centers for Disease Control and Yale Medicine. XEC stems from a combination of two previous Omicron ...

XEC became the dominant COVID strain this month. Scientists have been predicting this strain for a while. The CDC stated that XEC has caused 45% of all SARS-2 COVID-19 infections since Dec. 8th.

Invivyd (IVVD) announced that new in vitro neutralization data show continued neutralizing activity of PEMGARDA and pipeline candidate VYD2311 ...